About the ARK - Project
The overarching aim of ARK is to reduce the incidence of serious infections caused by antibiotic-resistant bacteria in the future, through substantially and safely reducing antibiotic use in hospitals now.
The specific research questions are:
- how can antibiotic prescription ‘review&revise’ strategies be implemented optimally to reduce antibiotic use safely within hospitals?
- can we build a feasible inexpensive package of interventions that increase prescriber compliance with ‘review&revise’, and patient acceptability of shorter antibiotic therapy durations driven by ‘review&revise’?
- are ‘review&revise’ strategies cost-effective across a range of scenarios reflecting plausible associations between antibiotic use now and future resistance leading to loss of antibiotic options?